Skip to content
TrialScanner

NCT04799158

A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease

Phase 2CompletedPHATLead

Registry record

Lead sponsor
Phathom Pharmaceuticals, Inc.
Conditions
Non-Erosive Gastro-Esophageal Reflux Disease; Heartburn
Primary completion
Dec 16, 2021Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04799158 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04799158: A Study to Evaluate the... | TrialScanner